Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Combination Product: NPM-119 (exenatide implant) low dose; Combination Product: NPM-119 (exenatide implant) high dose; Drug: Bydureon BCise (exenatide extended release) Sponsors: Vivani Medical, Inc; Medpace, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials